Cargando…
Phosphodiesterase Inhibitors: Could They Be Beneficial for the Treatment of COVID-19?
In March 2020, the World Health Organization declared the severe acute respiratory syndrome corona virus 2 (SARS-CoV2) infection to be a pandemic disease. SARS-CoV2 was first identified in China and, despite the restrictive measures adopted, the epidemic has spread globally, becoming a pandemic in a...
Autores principales: | Giorgi, Mauro, Cardarelli, Silvia, Ragusa, Federica, Saliola, Michele, Biagioni, Stefano, Poiana, Giancarlo, Naro, Fabio, Massimi, Mara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7432892/ https://www.ncbi.nlm.nih.gov/pubmed/32727145 http://dx.doi.org/10.3390/ijms21155338 |
Ejemplares similares
-
Cellular Redox Metabolism Is Modulated by the Distinct Localization of Cyclic Nucleotide Phosphodiesterase 5A Isoforms
por: Cardarelli, Silvia, et al.
Publicado: (2022) -
Structural Characterization of Murine Phosphodiesterase 5 Isoforms and Involvement of Cysteine Residues in Supramolecular Assembly
por: Giorgi, Mauro, et al.
Publicado: (2023) -
Use of the KlADH3 promoter for the quantitative production of the murine PDE5A isoforms in the yeast Kluyveromyces lactis
por: Cardarelli, Silvia, et al.
Publicado: (2017) -
Phosphodiesterase 4D Depletion/Inhibition Exerts Anti-Oncogenic Properties in Hepatocellular Carcinoma
por: Ragusa, Federica, et al.
Publicado: (2021) -
Targeting Cyclic AMP Signalling in Hepatocellular Carcinoma
por: Massimi, Mara, et al.
Publicado: (2019)